Rankings
▼
Calendar
UTHR
United Therapeutics Corporation
$24B
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.3B
+15.4% YoY
Gross Profit
$1.2B
90.2% margin
Operating Income
$539M
41.8% margin
Net Income
$340M
26.4% margin
EPS (Diluted)
$6.28
Cash Flow
Operating Cash Flow
$355M
Free Cash Flow
$308M
Stock-Based Comp.
$190M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$619M
Stockholders' Equity
$1.3B
Cash & Equivalents
$398M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.1B
+15.4%
Gross Profit
$1.2B
$986M
+17.9%
Operating Income
$539M
$292M
+84.2%
Net Income
$340M
$175M
+94.8%
← FY 2013
All Quarters
FY 2015 →
UTHR FY 2014 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena